Nyxoah SA (NYXH) vs Stereotaxis Inc. (STXS)

Nyxoah SA and Stereotaxis Inc. are both Medical Instruments & Supplies companies. Nyxoah SA is the larger, with a market value of $121.2M against $105.2M — 1.2× the size. Nyxoah SA grew revenue faster over the last twelve months: 366.2% against −5.46%. Stereotaxis Inc. has the higher net margin (−78.5% vs −446.4%) and the lower return on invested capital (−203.6% vs −117.8%). Across the 18 metrics below, Nyxoah SA leads on 10 and Stereotaxis Inc. on 8.

Valuation

Metric NYXH STXS Medical Instruments & Supplies median
P/E n/m n/m 33.75
P/S 2.52 3.36 2.52
P/B 0.65 8.25 2.48
Price to free cash flow n/m n/m 25.19
EV/EBITDA n/m n/m 14.62
EV/Sales 0.75 3.12 2.88
Earnings yield (227.03%) (23.76%) (2.67%)
Free cash flow yield (136.70%) (15.34%) 0.09%

Profitability

Metric NYXH STXS Medical Instruments & Supplies median
Gross margin 60.16% 55.57% 54.29%
Operating margin (391.25%) (75.68%) 1.07%
Net margin (446.39%) (78.45%) (1.61%)
Free cash flow margin (344.99%) (51.56%) 1.08%
Return on equity (124.41%) (344.36%) (1.32%)
Return on assets (68.23%) (48.76%) 0.00%
Return on invested capital (117.82%) (203.58%) 0.00%

Growth

Metric NYXH STXS Medical Instruments & Supplies median
Revenue growth (TTM) 366.24% (5.46%) 8.85%
EPS growth (last fiscal year) (36.22%) 16.67% 8.65%
Revenue growth, 5-year CAGR 170.14% 3.99% 9.17%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NYXH STXS Medical Instruments & Supplies median
Debt to equity 0.72 0.00 0.10
Current ratio 2.38 1.42 2.48
Net debt to EBITDA 0.08 0.65 0.89

Dividend

Metric NYXH STXS Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric NYXH STXS Medical Instruments & Supplies median
Market cap 121.19m 105.21m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack